Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-07

Clinical Trial Update: Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial comparing intralesional umbilical-cord mesenchymal stem cells, its conditioned medium, and triamcinolone acetonide for red…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)
  • intralesional umbilical-cord mesenchymal stem cells
  • umbilical-cord mesenchymal stem cells conditioned medium

Snippet

Sponsor: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Conditions: Keloid, Stem Cell | Phase 4 | Status: COMPLETED